FDAnews
www.fdanews.com/articles/180661-e-qures-bst-device-receives-marketing-approval-in-israel

E-QURE's BST Device Receives Marketing Approval in Israel

February 24, 2017

E-QURE has gained marketing approval from Israel’s Ministry of Health for its Bio-electrical Signal Therapy (BST) Device.

BST is an electrotherapy device for non-invasive treatment of hard-to-heal chronic wounds. — Cynthia Jessup

View today's stories